Who Owns Collegium Pharmaceutical Stock?
NASDAQ: COLLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 127.68%
- Institutions (% of float)
- 129.82%
- Held by insiders
- 1.65%
- Institutional holders
- 346
- Institutions 98.4%
- Insiders 1.6%
- Public and other 0.0%
Who owns Collegium Pharmaceutical stock?
Institutional investors own about 127.7% of Collegium Pharmaceutical's shares, spread across 346 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.65% of COLL.
The largest institutional holders are Blackrock Inc. (17.51%), Jupiter Topco LLC (6.91%) and State Street Corporation (5.70%). Together, the top 10 institutions control 62.5% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their COLL positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of COLL
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 5.44M | 17.51% | +6.0% |
| Jupiter Topco LLC | 2.15M | 6.91% | +100.0% |
| State Street Corporation | 1.77M | 5.70% | +15.9% |
| Fuller & Thaler Asset Management Inc. | 1.63M | 5.25% | +8.9% |
| Principal Financial Group, Inc. | 1.51M | 4.87% | -7.2% |
| Massachusetts Financial Services Co. | 1.49M | 4.78% | +5.8% |
| Renaissance Technologies, LLC | 1.41M | 4.53% | +3.1% |
| Vanguard Capital Management LLC | 1.38M | 4.44% | +3.5% |
| Eventide Asset Management LLC | 1.36M | 4.38% | -4.4% |
| Rubric Capital Management LP | 1.28M | 4.12% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of COLL
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 1.94M | 6.23% |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 1.56M | 5.02% |
| MUTUAL FUND SERIES TRUST-Eventide Gilead Fund | 1.34M | 4.33% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 977.96K | 3.15% |
| iShares Trust-iShares Russell 2000 ETF | 848.44K | 2.73% |
| Principal Funds, Inc-SmallCap Fund | 641.30K | 2.06% |
| MFS SERIES TRUST I-MFS New Discovery Fund | 585.15K | 1.88% |
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 475.64K | 1.53% |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 432.69K | 1.39% |
| AIM Growth Series -Invesco Main Street Small Cap Fd. | 411.48K | 1.32% |
Frequently asked questions
Who is the largest shareholder of Collegium Pharmaceutical?
Blackrock Inc. is the largest institutional shareholder of COLL, owning 17.51% of shares outstanding (5.44M shares) as of its latest 13F filing.
What percentage of Collegium Pharmaceutical is owned by institutions?
Institutions own about 127.7% of COLL shares and 129.8% of the public float.
How much of Collegium Pharmaceutical do insiders own?
Insiders, such as officers and directors, own about 1.65% of COLL shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.